Talphera (TLPH) Competitors $0.49 +0.02 (+5.25%) Closing price 07/8/2025 04:00 PM EasternExtended Trading$0.50 +0.01 (+1.79%) As of 07/8/2025 07:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TLPH vs. EGRX, MRSN, KPTI, STTK, LTRN, ELYM, PEPG, ITRM, AKTX, and ATHEShould you be buying Talphera stock or one of its competitors? The main competitors of Talphera include Eagle Pharmaceuticals (EGRX), Mersana Therapeutics (MRSN), Karyopharm Therapeutics (KPTI), Shattuck Labs (STTK), Lantern Pharma (LTRN), Eliem Therapeutics (ELYM), PepGen (PEPG), Iterum Therapeutics (ITRM), Akari Therapeutics (AKTX), and Alterity Therapeutics (ATHE). These companies are all part of the "pharmaceutical products" industry. Talphera vs. Its Competitors Eagle Pharmaceuticals Mersana Therapeutics Karyopharm Therapeutics Shattuck Labs Lantern Pharma Eliem Therapeutics PepGen Iterum Therapeutics Akari Therapeutics Alterity Therapeutics Talphera (NASDAQ:TLPH) and Eagle Pharmaceuticals (NASDAQ:EGRX) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, analyst recommendations, risk, institutional ownership and media sentiment. Do institutionals & insiders hold more shares of TLPH or EGRX? 37.7% of Talphera shares are held by institutional investors. Comparatively, 85.4% of Eagle Pharmaceuticals shares are held by institutional investors. 3.2% of Talphera shares are held by company insiders. Comparatively, 28.9% of Eagle Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Does the media prefer TLPH or EGRX? In the previous week, Talphera's average media sentiment score of 0.00 equaled Eagle Pharmaceuticals'average media sentiment score. Company Overall Sentiment Talphera Neutral Eagle Pharmaceuticals Neutral Which has more risk & volatility, TLPH or EGRX? Talphera has a beta of -0.11, meaning that its stock price is 111% less volatile than the S&P 500. Comparatively, Eagle Pharmaceuticals has a beta of 0.83, meaning that its stock price is 17% less volatile than the S&P 500. Is TLPH or EGRX more profitable? Eagle Pharmaceuticals' return on equity of 0.00% beat Talphera's return on equity.Company Net Margins Return on Equity Return on Assets TalpheraN/A -130.28% -59.25% Eagle Pharmaceuticals N/A N/A N/A Which has higher earnings & valuation, TLPH or EGRX? Eagle Pharmaceuticals has higher revenue and earnings than Talphera. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTalphera$650K15.37-$13M-$0.45-1.08Eagle Pharmaceuticals$257.55M0.16$35.64MN/AN/A Do analysts rate TLPH or EGRX? Talphera currently has a consensus target price of $5.00, suggesting a potential upside of 926.06%. Given Talphera's stronger consensus rating and higher possible upside, equities analysts plainly believe Talphera is more favorable than Eagle Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Talphera 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 2 Strong Buy rating(s) 3.50Eagle Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryEagle Pharmaceuticals beats Talphera on 7 of the 12 factors compared between the two stocks. Get Talphera News Delivered to You Automatically Sign up to receive the latest news and ratings for TLPH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TLPH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TLPH vs. The Competition Export to ExcelMetricTalpheraMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$9.49M$2.39B$5.47B$8.95BDividend YieldN/A1.80%5.25%4.06%P/E Ratio-1.088.9827.0020.10Price / Sales15.37729.50435.75120.29Price / CashN/A159.8036.8257.86Price / Book1.044.517.985.56Net Income-$13M$31.26M$3.16B$248.40M7 Day Performance8.05%3.57%2.40%4.67%1 Month Performance-5.40%1.28%2.19%6.64%1 Year Performance-45.15%1.08%33.82%21.31% Talphera Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TLPHTalphera1.6068 of 5 stars$0.49+5.2%$5.00+926.1%-45.9%$9.49M$650K-1.0819Positive NewsEGRXEagle PharmaceuticalsN/A$3.00flatN/A-45.9%$38.96M$257.55M0.00100MRSNMersana Therapeutics3.6559 of 5 stars$0.31+1.9%$5.20+1,577.4%-82.6%$38.64M$40.50M-0.53150KPTIKaryopharm Therapeutics3.8128 of 5 stars$4.47+5.7%$43.20+866.4%-60.8%$38.62M$145.24M-0.34380STTKShattuck Labs2.8411 of 5 stars$0.80+3.5%$7.50+838.3%-77.2%$38.29M$5.72M-0.58100LTRNLantern Pharma2.4413 of 5 stars$3.55+12.7%$25.00+604.2%-13.0%$38.27MN/A-1.9320Positive NewsGap UpHigh Trading VolumeELYMEliem TherapeuticsN/A$1.28+1.6%N/A-81.1%$38.08MN/A-2.429PEPGPepGen2.9141 of 5 stars$1.16+4.5%$7.67+560.9%-93.1%$37.96MN/A-0.3730ITRMIterum Therapeutics1.894 of 5 stars$0.93+0.7%$9.00+867.6%-28.2%$37.20MN/A-0.9410AKTXAkari Therapeutics1.3216 of 5 stars$1.13+1.8%N/A-61.1%$36.36MN/A0.009ATHEAlterity Therapeutics2.6224 of 5 stars$4.09+5.7%$12.00+193.4%+129.5%$36.28MN/A0.0010 Related Companies and Tools Related Companies Eagle Pharmaceuticals Alternatives Mersana Therapeutics Alternatives Karyopharm Therapeutics Alternatives Shattuck Labs Alternatives Lantern Pharma Alternatives Eliem Therapeutics Alternatives PepGen Alternatives Iterum Therapeutics Alternatives Akari Therapeutics Alternatives Alterity Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TLPH) was last updated on 7/9/2025 by MarketBeat.com Staff From Our PartnersA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Talphera, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Talphera With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TLPH Stock Alerts